Achieving lipid goals with rosuvastatin compared with simvastatin in high risk patients in real clinical practice: a randomized, open-label, parallel-group, multi-center study: the DISCOVERY-Beta study-Reference-Cited by-同舟云学术

Achieving lipid goals with rosuvastatin compared with simvastatin in high risk patients in real clinical practice: a randomized, open-label, parallel-group, multi-center study: the DISCOVERY-Beta study

Published:2008-12 Issue: Volume:Volume 4 Page:1407-1416
ISSN:1178-2048
Container-title:Vascular Health and Risk Management
language:en
Short-container-title:VHRM

Author:

Laks Toivo,Keba ,Leiner ,Merilind Euro,Petersen Mall,Reinmets ,Vali Sille,Soot ,Otter Karina M.

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Cardiology and Cardiovascular Medicine,Public Health, Environmental and Occupational Health,Hematology,General Medicine,Endocrinology, Diabetes and Metabolism

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness and safety assessment of calcium channel blockers compared to beta blockers in patients with angina: An observational study;PAK J PHARM SCI;2024

2. Efficacy of Lipid-Lowering Therapy during Cardiac Rehabilitation in Patients with Diabetes Mellitus and Coronary Heart Disease;Journal of Cardiovascular Development and Disease;2021-08-30

3. Bayesian Meta-Analysis: The Effect of Statins on the Treatment of Hypercholesterolemia;International Journal of Pharmacology;2018-02-01

4. Rosuvastatin Attenuates High-Salt and Cholesterol Diet Induced Neuroinflammation and Cognitive Impairment via Preventing Nuclear Factor KappaB Pathway;Neurochemical Research;2017-04-18

5. Race differences: modeling the pharmacodynamics of rosuvastatin in Western and Asian hypercholesterolemia patients;Acta Pharmacologica Sinica;2010-12-13